Systematic review / meta-analysis / 2014
Vitamin D supplementation reduced cancer mortality but not cancer incidence in trials.
A meta-analysis evaluated randomized controlled trials of vitamin D supplementation spanning 2 to 7 years. Supplementation at doses of 400 to 1,100 IU daily did not affect total cancer incidence across four trials with 4,333 cases (summary RR 1.00, 95% CI, 0.94 to 1.06). However, doses of 400 to 833 IU daily significantly reduced cancer mortality across three trials with 1,190 deaths (summary RR 0.88, 95% CI, 0.78 to 0.98).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- Participants across 4 randomized controlled trials (4,333 cancer cases, 1,190 deaths)
- What was measured
- Total cancer incidence and mortality
THE PAPER
Vitamin D supplements and cancer incidence and mortality: a meta-analysis.
Keum N, Giovannucci E. Br J Cancer, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.